Samsara Allowance for Doubtful Accounts Receivable (Current) increased by 17.8% to $11.90M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 38.4%, from $8.60M to $11.90M. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.10M | $6.20M | $6.70M | $7.80M | $8.30M | $7.60M | $8.60M | $9.10M | $10.70M | $10.10M | $11.90M |
| QoQ Change | — | +1.6% | +8.1% | +16.4% | +6.4% | -8.4% | +13.2% | +5.8% | +17.6% | -5.6% | +17.8% |
| YoY Change | — | — | — | — | +36.1% | +22.6% | +28.4% | +16.7% | +28.9% | +32.9% | +38.4% |